Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Anastasia Hepburn.
Newcastle Authors
Title
Year
Full text
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer
2024
Adriana Buskin
Dr Emma Scott
Ryan Nelson
Dr Luke Gaughan
Professor Craig Robson
et al.
Engineering prostate cancer in vitro: what does it take?
2023
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer
2023
Dr Emma Scott
Emily Archer Goode
Rebecca Garnham
Dr Kirsty Hodgson
Maggie Orozco Moreno
et al.
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression
2023
Dr Anastasia Hepburn
Dr Cole Sims
Dr Adriana Buskin
Professor Rakesh Heer
Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies
2020
Dr Anastasia Hepburn
Emma Curry
Dr Mohammad Moad
Laura Wilson
Parmveer Singh
et al.
Propagation of human prostate tissue from induced pluripotent stem cells
2020
Dr Anastasia Hepburn
Laura Wilson
Evangelia Kounatidou
Amy Barnard
Philip Berry
et al.
Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y)
2019
Dr Anastasia Hepburn
Laura Wilson
Evangelia Kounatidou
Amy Barnard
Philip Berry
et al.
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
2019
Dr Anastasia Hepburn
Professor Rakesh Heer
Urothelial carcinoma stem cells: Current concepts, controversies, and methods
2018
Dr Mohammad Moad
Dr Deepali Pal
Dr Anastasia Hepburn
Dr Stuart Williamson
Laura Wilson
et al.
A novel model of urinary tract differentiation, tissue regeneration, and disease: Reprogramming human prostate and bladder cells into induced pluripotent stem cells
2013
Dr Stuart Williamson
Dr Anastasia Hepburn
Laura Wilson
Professor Hing Leung
Professor Craig Robson
et al.
Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer
2013
Dr Mohammad Moad
Dr Anastasia Hepburn
Professor Majlinda Lako
Dr Deepali Pal
Professor Rakesh Heer
et al.
Generation of induced pluripotent stem cells from human urinary tract cells
2013
Dr Anastasia Hepburn
Dr Luke Gaughan
Dr Stuart Williamson
Dr Deepali Pal
Dr Mohammad Moad
et al.
Investigating the regulation and effects on androgen receptor expression using a novel stem cell environment model of castration resistant prostate cancer
2013
Professor Rakesh Heer
Dr Anastasia Hepburn
Dr Stuart Williamson
Dr Amy Kennedy
Dr Amira El-Sherif
et al.
Renal differentiation from adult spermatogonial stem cells
2013
Dr Deepali Pal
Dr Mohammad Moad
Dr Anastasia Hepburn
Dr Stuart Williamson
Professor Craig Robson
et al.
Reply from Authors re: "Reprogramming Stromal Cell from the Urinary Tract and Prostate: A Trip to Pluripotency and Back?"
2013
Dr Deepali Pal
Dr Mohammad Moad
Dr Anastasia Hepburn
Dr Stuart Williamson
Professor Craig Robson
et al.
Reply from Authors re: Felix Wezel, Jennifer Southgate. Reprogramming Stromal Cells from the Urinary Tract and Prostate: A Trip to Pluripotency and Back? Eur Urol 2013;64:762-4
2013
Dr Anastasia Hepburn
Laura Wilson
Professor Craig Robson
Professor Rakesh Heer
Stockpiling testosterone; A unique mechanism of progression to castrate resistant disease
2013
Dr Stuart Williamson
Dr Anastasia Hepburn
Laura Wilson
Dr Kelly Coffey
Claudia Ryan-Munden
et al.
Human α
2
β
1
HI
CD133
+VE
Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor
2012
Dr Anastasia Hepburn
Dr Stuart Williamson
Dr Amira El-Sherif
Dr Neha Sahay
Huw Thomas
et al.
Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling
2012
Dr John Blackwood
Dr Stuart Williamson
Professor Laura Greaves
Laura Wilson
Dr Anastasia Hepburn
et al.
In situ
lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells
2011
Dr Stuart Williamson
Dr Anastasia Hepburn
Professor Craig Robson
Professor Rakesh Heer
An update on the prostate cancer stem cell model-CD133+ve stem cell enriched human prostate cells express active androgen receptor
2011
Dr Deepali Pal
Dr Stuart Williamson
Professor Craig Robson
Dr Anastasia Hepburn
Professor Rakesh Heer
et al.
Characterising potential for pluripotency induction in human prostate tissue
2011
Dr Stuart Williamson
Dr Anastasia Hepburn
Professor Craig Robson
Professor Rakesh Heer
Comparative meta-analysis of the human prostate stem cell transcriptome demonstrates that progenitor cells are the site of malignant transformation
2011
Dr Anastasia Hepburn
Dr Stuart Williamson
Professor Craig Robson
Professor Rakesh Heer
Side population in human bladder cancer enriches for cancer stem cells that can be targeted by MAPK inhibition
2011
Professor Rakesh Heer
Dr Anastasia Hepburn
Dr Tim Cheek
Rob Pickard
Professor Hing Leung
et al.
Phenotypic Modulation of Human Urinary Tract Stroma-derived Fibroblasts by Transforming Growth Factor β3
2010
Dr Anastasia Hepburn
Professor Craig Robson
Professor Nicola Curtin
Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer
2007
Dr Anastasia Hepburn
Daniel Ozanne
Professor David Neal
Professor Craig Robson
The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway
2003